Metropolitan Life Insurance Company (MetLife)’s Align Technology ALGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,873
Closed -$942K 93
2024
Q1
$942K Sell
2,873
-26
-0.9% -$7.63K 0.04% 344
2023
Q4
$794K Sell
2,899
-46
-2% -$10.9K 0.04% 358
2023
Q3
$899K Sell
2,945
-156
-5% -$53.9K 0.05% 319
2023
Q2
$1.1M Sell
3,101
-149
-5% -$47.4K 0.05% 304
2023
Q1
$1.09M Sell
3,250
-952
-23% -$281K 0.06% 306
2022
Q4
$886K Buy
4,202
+31
+0.7% +$6.21K 0.04% 387
2022
Q3
$864K Sell
4,171
-90
-2% -$23.2K 0.04% 384
2022
Q2
$1.01M Sell
4,261
-111
-3% -$34.1K 0.04% 366
2022
Q1
$1.91M Sell
4,372
-7,635
-64% -$3.72M 0.07% 269
2021
Q4
$7.89M Sell
12,007
-294
-2% -$189K 0.11% 147
2021
Q3
$8.19M Sell
12,301
-265
-2% -$180K 0.12% 138
2021
Q2
$7.68M Sell
12,566
-368
-3% -$218K 0.11% 148
2021
Q1
$7M Sell
12,934
-719
-5% -$397K 0.1% 156
2020
Q4
$7.3M Sell
13,653
-522
-4% -$235K 0.11% 151
2020
Q3
$4.64M Sell
14,175
-567
-4% -$173K 0.08% 201
2020
Q2
$4.05M Buy
14,742
+366
+3% +$82.4K 0.07% 217
2020
Q1
$2.5M Sell
14,376
-214
-1% -$51.2K 0.05% 316
2019
Q4
$4.07M Sell
14,590
-394
-3% -$98.2K 0.07% 257
2019
Q3
$2.71M Buy
14,984
+13
+0.1% +$2.7K 0.05% 355
2019
Q2
$4.1M Buy
14,971
+643
+4% +$194K 0.07% 242
2019
Q1
$4.07M Sell
14,328
-460
-3% -$110K 0.07% 222
2018
Q4
$3.1M Sell
14,788
-3
-0% -$758 0.06% 255
2018
Q3
$5.79M Sell
14,791
-226
-2% -$83.4K 0.1% 175
2018
Q2
$5.14M Buy
15,017
+129
+0.9% +$38.5K 0.08% 206
2018
Q1
$3.74M Buy
14,888
+61
+0.4% +$15.7K 0.05% 264
2017
Q4
$3.29M Sell
14,827
-23,032
-61% -$5.23M 0.04% 305
2017
Q3
$7.05M Sell
37,859
-1,973
-5% -$338K 0.04% 372
2017
Q2
$5.98M Sell
39,832
-33,291
-46% -$4.51M 0.04% 464
2017
Q1
$8.39M Buy
73,123
+318
+0.4% +$32.1K 0.06% 322
2016
Q4
$7M Sell
72,805
-747
-1% -$69.4K 0.05% 376
2016
Q3
$6.9M Buy
73,552
+1,738
+2% +$157K 0.05% 372
2016
Q2
$5.79M Buy
71,814
+2,202
+3% +$168K 0.04% 442
2016
Q1
$5.06M Buy
69,612
+1,963
+3% +$129K 0.04% 508
2015
Q4
$4.46M Sell
67,649
-29
-0% -$1.86K 0.03% 555
2015
Q3
$3.84M Sell
67,678
-392
-0.6% -$23.4K 0.03% 624
2015
Q2
$4.27M Buy
68,070
+471
+0.7% +$27.8K 0.03% 620
2015
Q1
$3.64M Buy
67,599
+2,537
+4% +$145K 0.03% 663
2014
Q4
$3.64M Buy
65,062
+319
+0.5% +$16.9K 0.03% 699
2014
Q3
$3.35M Buy
64,743
+1,076
+2% +$58.6K 0.02% 706
2014
Q2
$3.57M Sell
63,667
-52,556
-45% -$2.73M 0.02% 717
2014
Q1
$6.02M Buy
116,223
+57,617
+98% +$3.23M 0.04% 451
2013
Q4
$3.35M Buy
58,606
+1,060
+2% +$57.1K 0.02% 714
2013
Q3
$2.77M Sell
57,546
-2,050
-3% -$89.5K 0.02% 763
2013
Q2
$2.21M Buy
+59,596
New +$2.05M 0.02% 837

Other funds holding ALGN

Metropolitan Life Insurance Company (MetLife)'s ALGN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Align Technology (ALGN) in Q2 2024, closing a stake of 2,873 shares — an estimated $942K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ALGN in Q2 2013 and held it in 44 quarters. The position peaked at $8.39M in Q1 2017. 768 funds tracked by Wall St. Rank hold ALGN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Align Technology position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,873 Align Technology shares in Q2 2024, an estimated $942K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Align Technology in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Align Technology position peaked at $8.39M in Q1 2017.
  • 768 funds tracked by Wall St. Rank held Align Technology as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.